HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bradley S Dixon Selected Research

cholesterol-binding protein

3/2022PATENCY-2 trial of vonapanitase to promote radiocephalic fistula use for hemodialysis and secondary patency.
1/2019A randomized trial of vonapanitase (PATENCY-1) to promote radiocephalic fistula patency and use for hemodialysis.
4/2017Arteriovenous fistula patency in the 3 years following vonapanitase and placebo treatment.
8/2014Human type I pancreatic elastase treatment of arteriovenous fistulas in patients with chronic kidney disease.
4/2013A multi-center, dose-escalation study of human type I pancreatic elastase (PRT-201) administered after arteriovenous fistula creation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bradley S Dixon Research Topics

Disease

9Arteriovenous Fistula
03/2022 - 01/2002
7Fistula
03/2022 - 01/2005
4Pathologic Constriction (Stenosis)
08/2014 - 09/2002
3Thrombosis (Thrombus)
05/2009 - 01/2005
1Albuminuria
11/2016
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2016
1Hyperkalemia
12/2014
1Kidney Diseases (Kidney Disease)
08/2014
1Chronic Renal Insufficiency
08/2014
1Hypertension (High Blood Pressure)
09/2012
1Membranous Glomerulonephritis (Membranous Nephropathy)
09/2012
1Hypovolemia
09/2012
1Hypoalbuminemia
09/2012
1Hypoaldosteronism (Hyporeninemic Hypoaldosteronism)
09/2012
1Nephrotic Syndrome (Syndrome, Nephrotic)
09/2012
1Edema (Dropsy)
09/2012
1Proteinuria
09/2012
1Infections
05/2008
1Atherosclerosis
09/2002
1Fibromuscular Dysplasia
09/2002

Drug/Important Bio-Agent (IBA)

5cholesterol-binding proteinIBA
03/2022 - 04/2013
5Pancreatic Elastase (Elastase)IBA
03/2022 - 04/2013
3Pharmaceutical PreparationsIBA
03/2022 - 09/2012
2SolutionsIBA
03/2022 - 01/2019
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2009 - 01/2005
2Dipyridamole (Persantine)FDA LinkGeneric
05/2009 - 01/2005
2Clopidogrel (Plavix)FDA Link
05/2008 - 01/2005
1Biomarkers (Surrogate Marker)IBA
11/2016
1ZirconiumIBA
12/2014
1Dihydrotachysterol (AT 10)IBA
08/2014
1Cyclosporine (Ciclosporin)FDA LinkGeneric
09/2012
1Lisinopril (Prinivil)FDA LinkGeneric
09/2012
1MineralocorticoidsIBA
09/2012
1Prednisone (Sone)FDA LinkGeneric
09/2012
1SaltsIBA
09/2012
1SodiumIBA
09/2012
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
09/2012
1AldosteroneIBA
09/2012
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
05/2008
1Dipyridamole Drug Combination AspirinFDA LinkGeneric
01/2005

Therapy/Procedure

11Renal Dialysis (Hemodialysis)
03/2022 - 01/2002
1Aftercare (After-Treatment)
09/2012
1Central Venous Catheters
05/2008
1Stents
09/2002